Justice Ruth Bader Ginsburg receiving chemotherapy for a ‘recurrence of cancer’

Web Exclusives

FILE – In this Dec. 17, 2019, file photo, Supreme Court Justice Ruth Bader Ginsburg looks up as she speaks about the antics of her son as she speaks with author Jeffrey Rosen at the National Constitution Center Americas Town Hall at the National Museum of Women in the Arts in Washington. (AP Photo/Steve Helber, File)

WASHINGTON — Justice Ruth Bader Ginsburg said Friday she is receiving chemotherapy for a recurrence of cancer, but has no plans to retire from the Supreme Court.

The 87-year-old Ginsburg, who spent time in the hospital this week for a possible infection, said her treatment so far has succeeded in reducing lesions on her liver and that she will continue chemotherapy sessions every two weeks.

“I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that,” Ginsburg said in a statement issued by the court.

Full statement:

“On May 19, I began a course of chemotherapy (gemcitabine) to treat a recurrence of cancer. A periodic scan in February followed by a biopsy revealed lesions on my liver. My recent hospitalizations to remove gall stones and treat an infection were unrelated to this recurrence.Immunotherapy first essayed proved unsuccessful. The chemotherapy course, however, is yielding positive results. Satisfied that my treatment course is now clear, I am providing this information.My most recent scan on July 7 indicated significant reduction of the liver lesions and no new disease. I am tolerating chemotherapy well and am encouraged by the success of my current treatment. I will continue bi-weekly chemotherapy to keep my cancer at bay, and am able to maintain an active daily routine. Throughout, I have kept up with opinion writing and all other Court work.I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that.”

The Associated Press contributed to this report.

Good News

More Good News